NCT01587950 The Effects of Potassium Nitrate in Reducing Dentinal Hypersensitivity Status COMPLETED Phase PHASE1
NCT01587924 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Status COMPLETED Phase PHASE2
NCT01587898 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis Status COMPLETED Phase PHASE2
NCT01587807 A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057 Status COMPLETED Phase PHASE1
NCT01587768 WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics Status COMPLETED Phase N/A
NCT01587742 IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer Status COMPLETED Phase N/A
NCT01587716 A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345. Status COMPLETED Phase PHASE1
NCT01587703 A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers Status COMPLETED Phase PHASE1
NCT01587339 Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy Status COMPLETED Phase N/A
NCT01584843 Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus Status COMPLETED Phase PHASE3
NCT01583530 Study of Belimumab Administered Subcutaneously to Healthy Subjects Status COMPLETED Phase PHASE1
NCT01583036 An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed Status COMPLETED Phase PHASE1
NCT01582997 A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors Status COMPLETED Phase PHASE1
NCT01582932 Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT01578941 An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine Status COMPLETED Phase PHASE4